Jade Biosciences (JBIO) Other Non Operating Income (2020 - 2026)
Jade Biosciences (JBIO) posted Other Non Operating Income of -$9000.0 for Q1 2026, down 109.89% on a QoQ basis from $91000.0 in Q4 2025.
Jade Biosciences (JBIO) Other Non Operating Income (2020 - 2026) Analysis & Trends
Jade Biosciences' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$9000.0 for Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to -$9000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54000.0 (down 96.12% YoY) and the FY2025 annual result came in at $63000.0, up 431.58% from the prior year.
- Other Non Operating Income was -$9000.0 for Q1 2026 at Jade Biosciences, down from $91000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.8 million in Q4 2022 and bottomed at -$28000.0 in Q3 2025.
- A 5-year average of $477666.7 and a median of $47500.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 24942.86% in 2022, while the deepest fall reached 500.0% in 2022.
- Jade Biosciences' Other Non Operating Income stood at $1.8 million in 2022, then slumped by 99.94% to $1000.0 in 2023, then soared by 138900.0% to $1.4 million in 2024, then slumped by 93.45% to $91000.0 in 2025, then slumped by 109.89% to -$9000.0 in 2026.
- Business Quant data shows JBIO's Other Non Operating Income at -$9000.0 in Q1 2026, $91000.0 in Q4 2025, and -$28000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,000.00 |
| Dec 31, 2025 | 91,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | -3,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | 109,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | -64,000.00 |
| Jun 30, 2020 | -577,000.00 |